.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A03A_DrugsForFunctionalGastrointestinalDisorders.A03AB13_Bevonium.Bevonium .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A03A_DrugsForFunctionalGastrointestinalDisorders.A03AB13_Bevonium.Bevonium| name: | Bevonium | |
| ATC code: | A03AB13 | route: | oral |
| compartments: | 1 | |
| dosage: | 20 | mg |
| volume of distribution: | 3 | L |
| clearance: | 5 | L/h |
| other parameters in model implementation | ||
Bevonium is an antimuscarinic (anticholinergic) drug historically used as a spasmolytic agent, chiefly for conditions involving gastrointestinal and urinary tract smooth muscle spasm. It is no longer widely used or approved in most countries.
Pharmacokinetic parameter estimates for bevonium are not available in the literature, and no peer-reviewed pharmacokinetic studies have been identified. The values below are estimated based on general pharmacokinetic properties of antimuscarinic agents administered orally.